Director at Bausch & Lomb (NYSE: BLCO) gets 15,842-share RSU award

Rhea-AI Filing Summary

KAVANAGH SARAH B reported acquisition or exercise transactions in this Form 4 filing.

Bausch & Lomb Corp director Sarah B. Kavanagh received an equity grant of 15,842 common shares-equivalent on an award date price of $15.78 per share. The grant reflects annual restricted share units for non-employee directors under the company’s 2022 Omnibus Incentive Plan.

The RSUs are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders and will be settled in common shares. Following this award, Kavanagh directly holds 69,541 common shares, highlighting this as compensation-related rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KAVANAGH SARAH B

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	15,842	$15.78	$250K

Holdings After Transaction: Common Shares, No Par Value — 69,541 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 15,842 shares Award date price: $15.78 per share Shares held after grant: 69,541 shares

3 metrics

RSU grant size 15,842 shares Annual equity award to non-employee director

Award date price $15.78 per share Reporting price for RSU grant

Shares held after grant 69,541 shares Director’s direct common share holdings after transaction

Key Terms

restricted share units ("RSUs"), 2022 Omnibus Incentive Plan, annual meeting of shareholders

3 terms

restricted share units ("RSUs") financial

"Reflects the annual grant of restricted share units ("RSUs") to non-employee directors"

2022 Omnibus Incentive Plan financial

"under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated"

annual meeting of shareholders financial

"scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KAVANAGH SARAH B

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN L4K 4B4

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/26/2026		A		15,842(1)	A	$15.78	69,541	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.

	/s/ Debra E. Levin, attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Bausch & Lomb (BLCO) director Sarah Kavanagh receive in this Form 4?

Sarah B. Kavanagh received an award of 15,842 common shares-equivalent as restricted share units. The grant reflects her annual equity compensation as a non-employee director under Bausch & Lomb’s 2022 Omnibus Incentive Plan.

Is the Bausch & Lomb (BLCO) Form 4 a market purchase or a compensation grant?

The Form 4 shows a compensation-related grant, not a market purchase. It records an annual restricted share unit award to a non-employee director, settled into common shares rather than bought on the open market.

At what price was the Bausch & Lomb (BLCO) director share award valued?

The 15,842-share award was valued at an award date price of $15.78 per share. This price is used for reporting the equity grant, which is provided as part of director compensation rather than a cash transaction.

When do the RSUs in this Bausch & Lomb (BLCO) grant vest?

The restricted share units are scheduled to vest on the date immediately before the conclusion of the next annual meeting of shareholders. Once vested, the RSUs will be settled in Bausch & Lomb common shares with no par value.

How many Bausch & Lomb (BLCO) shares does Sarah Kavanagh hold after this transaction?

After the award, Sarah B. Kavanagh directly holds 69,541 common shares. This total includes the newly granted restricted share unit award and reflects her direct ownership position reported in the Form 4.